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Abstract 
 This paper attempts to highlight the growth and development of Covid-19 Vaccine literature and 
make the quantitative and qualitative assessment by way of analyzing various features of research output 
and Citations impact based on the Web of Science database. A total of 433 publications were published 
on Covid-19 Vaccine, which received 52567 Citations during 1989-2020. The average number of 
citations per publication was 121.4. The research was peaked in 2020 with 97(Which received a minimum 
of 500 Citations) Publications and the highest number of citations (14623) were received in 2020. USA 
had the highest share 229 of publications and received 29027 Citations followed by the Peoples Republic 
of China with 13798 Citations for 114 publications, the UK with 4314 Citations for 35 publications, 
Germany with 3404 Citations for 33 publications, the Netherlands with 28 Citations for 28 publications. 
The study found that India has recorded 705 Citations for 9 Publications. The highly productive 
Institutions were: National Institute of Allergy and Infectious Diseases from the USA with 39 publications 
and received 6076 Citations followed by University N Carolina- the USA with 31 publications and 4118 
citations, University Hong Kong- China with 23 publications and 3546 citations, New York Blood Centre 
with 21 publications and 2931 citations. The highly productive (Citations) journals are JOURNAL OF 
VIROLOGY with 5724 Citations for 53  Publications, SCIENCE with 4163 Citations for 13 publications, 
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF 
AMERICA  with 3113 Citations for 20 publications, NATURE with 2250 Citations for 13 publications, 
and LANCET with 1528 Citations for 8 publications. This may be attributed to a new field for research to 
demystify the phenomena of Covid-19 Vaccine. There were 18 single Author publications by the scientists 
and 2906 multi-Author collaborative publications. The Collaboration Index is 7.05 and Citing Articles 
15055. 
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INTRODUCTION 
Scientometric evaluations have its own characteristics. Scientometric researchers are 
exploring features of information processes in scientific research but are far from finding the 
solution to all problems. Scientometric studies covering all quantitative and qualitative aspects of 
the science of science also include quantitative and qualitative analysis of scientific literature 
(bibliometrics) as a reflection of science development and state-of-the-art compared science to an 
edifice building upon the past, and indicated the potential for examining science through its 
literature, since published papers being the end product of much science research and its 
“building blocks” show the structure of this “edifice.” Many Scientometric studies have appeared 




The objective of the study was to perform a Scientometric analysis of all Covid-19 Vaccine 
publications in the world. The parameters studied include:  
• To find out growth of Publications and Citations; 
• To find out country-wise distribution of publications and Citations; 
• To verify H-Index, G-Index and M-Index;  
• To find out publications share of highly productive countries  
• To find out publication and citations according to number of collaborating countries 
(Single Country and Multiple Country;  
• To find out highly cited publications;  
• To find out highly preferred journals and  
• To document quality of research output; 
 
MATERIALS AND METHODS  
Web of Science database was used for retrieving data on Covid-19 Vaccine for all years 
using the search term ‘Covid-19 Vaccine’ or ‘Coronavirus Vaccine’ in ‘topic’ field. Records 
pertaining to Covid-19 Vaccine were retrieved only from 1989 onwards. A total of 433 
publications and 52567 Citations received to these publications were transferred to spread sheet 
application, Biblioshiny, Histcite, and analyzed the data as per objectives of the study.  
 
Geographical wise distribution of Publications and Citations 
In all, there were 51 countries involved in research in Covid-19 Vaccine, which received 
at least 50 Citations per paper. The publication share of highly productive and Highly Cited 
Works Countries (≥50 Citations) on Covid-19 Vaccine is given in Table 1. USA had the highest 
share 229 of publications and received 29027 Citations followed by Peoples Republic of China 
with 13798 Citations for 114 publications, UK with 4314 Citations for 35 publications, Germany 
with 3404 Citations for 33 publications, Netherland with 28 Citations for 28 publications. The 
study found that India has recorded 705 Citations for 9 Publications. It is also noted that 10 
countries are registered nearly 1000-3000 Citations and 18 Countries with single publication and 
received 50-200 Citations.  
Table 1: Most Cited Country on Covid-19 
 
Publication Impact Citation Impact  
Country  Records  TGCS  Country Records TGCS  
1 USA 229 29027  USA 229 29027  
2 Peoples R China 114 13798  Peoples R China 114 13798  
3 UK 35 4314  UK 35 4314  
4 Germany 33 3404  Germany 33 3404  
5 Netherlands 28 3007  Canada 23 3353  
6 Canada 23 3353  Netherlands 28 3007  
7 Spain 18 1922  France 17 2864  
8 Switzerland 18 1990  Switzerland 18 1990  
9 France 17 2864  Spain 18 1922  
10 South Korea 14 1188  South Korea 14 1188  
11 India 9 705  Australia 7 944  
12 Saudi Arabia 9 806  Saudi Arabia 9 806  
13 Taiwan 8 757  Singapore 7 798  
14 Australia 7 944  Taiwan 8 757  
15 Italy 7 499  India 9 705  
16 Singapore 7 798  New Zealand 2 656  
17 Japan 6 382  Thailand 4 630  
18 Unknown 6 407  Finland 2 587  
19 Belgium 4 302  Poland 3 557  
20 Iran 4 332  Norway 3 555  
21 Thailand 4 630  Italy 7 499  
22 Ireland 3 184  South Africa 3 495  
23 Israel 3 370  Unknown 6 407  
24 Norway 3 555  Japan 6 382  
25 Poland 3 557  Israel 3 370  
26 Qatar 3 345  Qatar 3 345  
27 South Africa 3 495  Iran 4 332  
28 Sweden 3 313  Sweden 3 313  
29 Egypt 2 111  Belgium 4 302  
30 Finland 2 587  Mexico 2 226  
31 Malaysia 2 108  Kenya 1 198  
32 Mexico 2 226  Ireland 3 184  
33 New Zealand 2 656  Egypt 2 111  
34 Argentina 1 79  Malaysia 2 108  
35 Austria 1 76  Czech Republic 1 104  
36 Brazil 1 67  Pakistan 1 91  
37 Chile 1 69  Argentina 1 79  
38 Colombia 1 54  Iraq 1 79  
39 Czech Republic 1 104  Jordan 1 79  
40 Hungary 1 74  U Arab Emirates 1 79  
41 Iraq 1 79  Austria 1 76  
42 Jordan 1 79  Hungary 1 74  
43 Kenya 1 198  Chile 1 69  
44 Nigeria 1 50  Brazil 1 67  
45 Pakistan 1 91  Turkey 1 64  
46 Palestine 1 63  Palestine 1 63  
47 Portugal 1 57  Portugal 1 57  
48 Russia 1 54  Ukraine 1 55  
49 Turkey 1 64  Colombia 1 54  
50 U Arab Emirates 1 79  Russia 1 54  
51 Ukraine 1 55 Nigeria 1 50 
Table 2: Country Collaboration 
From To Frequency From To Frequency 
USA CHINA 50 AUSTRALIA SWITZERLAND 2 
USA SWITZERLAND 14 CANADA CHINA 2 
USA UNITED 
KINGDOM 
13 CANADA SPAIN 2 
USA NETHERLANDS 10 CANADA SWITZERLAND 2 
GERMANY NETHERLANDS 9 CANADA UNITED 
KINGDOM 
2 
CANADA USA 8 CHINA AUSTRALIA 2 
USA FRANCE 8 FRANCE BELGIUM 2 
CHINA UNITED 
KINGDOM 
7 FRANCE GERMANY 2 
USA GERMANY 7 GERMANY IRELAND 2 
USA SPAIN 7 GERMANY MEXICO 2 
UNITED 
KINGDOM 
GERMANY 6 GERMANY SWITZERLAND 2 
USA SAUDI ARABIA 6 INDIA IRAN 2 
CHINA GERMANY 5 NETHERLANDS IRELAND 2 
USA AUSTRALIA 5 SWITZERLAND SAUDI ARABIA 2 
USA KOREA 5 THAILAND INDIA 2 
FRANCE CHINA 4 THAILAND IRAN 2 
UNITED 
KINGDOM 
SWITZERLAND 4 UNITED 
KINGDOM 
NETHERLANDS 2 
CANADA FRANCE 3 USA EGYPT 2 
CHINA JAPAN 3 USA POLAND 2 
CHINA SINGAPORE 3 USA QATAR 2 
CHINA SWITZERLAND 3 AUSTRALIA NETHERLANDS 1 
FRANCE NETHERLANDS 3 AUSTRALIA SAUDI ARABIA 1 




3 CANADA BELGIUM 1 
UNITED 
KINGDOM 





Figure: Three Field Plot (Countries, Institutions and Authors) 
 
Table 3: Single Vs Multiple Country Collaboration 
Country Articles Freq SCP MCP MCP_Ratio 
USA 176 0.41608 119 57 0.324 
CHINA 88 0.20804 62 26 0.295 
NETHERLANDS 17 0.04019 8 9 0.529 
UNITED 
KINGDOM 
17 0.04019 6 11 0.647 
GERMANY 15 0.03546 9 6 0.4 
CANADA 14 0.0331 10 4 0.286 
SPAIN 11 0.026 6 5 0.455 
KOREA 10 0.02364 7 3 0.3 
ITALY 8 0.01891 7 1 0.125 
SINGAPORE 8 0.01891 5 3 0.375 
SWITZERLAND 8 0.01891 0 8 1 
INDIA 7 0.01655 4 3 0.429 
FRANCE 5 0.01182 3 2 0.4 
SAUDI ARABIA 5 0.01182 1 4 0.8 
BELGIUM 3 0.00709 2 1 0.333 
JAPAN 3 0.00709 2 1 0.333 
NORWAY 3 0.00709 2 1 0.333 
AUSTRALIA 2 0.00473 1 1 0.5 
FINLAND 2 0.00473 1 1 0.5 
IRAN 2 0.00473 1 1 0.5 
IRELAND 2 0.00473 0 2 1 
MALAYSIA 2 0.00473 1 1 0.5 
SOUTH AFRICA 2 0.00473 2 0 0 
SWEDEN 2 0.00473 0 2 1 
THAILAND 2 0.00473 2 0 0 
AUSTRIA 1 0.00236 1 0 0 
CHILE 1 0.00236 0 1 1 
COLOMBIA 1 0.00236 0 1 1 
EGYPT 1 0.00236 0 1 1 
ISRAEL 1 0.00236 1 0 0 
JORDAN 1 0.00236 1 0 0 
KENYA 1 0.00236 0 1 1 
PAKISTAN 1 0.00236 1 0 0 




The highest number of collaboration by USA with China(50), Switzerland(14), UK(13), 
Netherland(10), France(8), Germany(7) and so on followed by Germany with Netherland(9), 
Ireland(2), Mexico(2) and Switzerland(2) Publications. The figure shows Corresponding author’s 
Country i.e. Single Vs Multiple Country Collaboration. The MCP Ratio from 0.12 to 1 and also 
showing single country collaboration is high compare with Multiple Country Collaboration.  
 
Institution wise distribution of Citations 
Among Institutions, the highly productive Institutions were: National Institute of Allergy 
and Infectious Diseases from USA with 39 publications and received 6076 Citations followed by 
University N Carolina- USA with 31 publications and 4118 citations, University Hong Kong- 
China with 23 publications and 3546 citations, New York Blood Ctr with 21 publications and 
2931 citations. USA and China Institutes are dominating in terms of Citation and Publications in 
the field of Covid-19 Vaccine research. 26 Institutes are recorded 1000 and above Citations. 





 Institution Records TGC
S  
1 NIAID 39 6076  Vanderbilt University 11 1638  
2 University N Carolina 31 4118  University Victoria 2 1523  
3 University Hong Kong 23 3546  University Minnesota 8 1449  
4 New York Blood Ctr 21 2931  British Columbia Canc 
Agcy 
1 1374  
5 Chinese Academy of 
Science 
18 2788  British Columbia Ctr 
Dis Control 
1 1374  
6 Beijing Inst 
Microbiology & 
Epidemiology 
18 2703  National Microbiology 
Lab 
1 1374  
7 Harvard University 14 2280  CNRS 5 1353  
8 Inst Pasteur 9 2030  University Texas 
Austin 
3 1330  
9 University Washington 9 1966  Chinese Acad Med Sci 14 1325  
10 University Iowa 20 1945  Fred Hutchinson Canc 
Res Ctr 
2 1301  
11 Fudan University 15 1801  Tsinghua University 7 1109  
12 University British 
Columbia 
5 1734  University Utrecht 9 1076  
13 Ctr Dis Control & 
Prevent 
13 1640  Childrens Hosp 3 1061  
 
Figure: Three filed plot (Institutions, Countries and Authors) 
 
Year wise distribution of Citations 
Table 5 gives the year wise distribution of publications and Citations on Covid-19 
Vaccine. Out of total 433 Publications, - the maximum numbers of Citations are in the year 2020 
received 14623 Citations followed by 2004 with 5238 Citations for 39 publications, 4394 
Citations in the year 2005. 15 Years registered the range of Citations 1045-14623. The below 
table 6 shows Average Citation Per year. The table 5 and 6 shows the year wise distribution of 
articles and the number of citations there of, total number of citations and average citations per 
article. From the table it has been found that there is a total of 52567 citations distributed among 
159 journal. It is also seen that the number of articles is increasing but not in a uniform manner. 
Similarly, the number of citations per year is varying from year to year.  
Table 5: Year wise distribution of Publications and Citations 
# Year  Records  TGCS   Year Records TGCS   Year Records TGCS  
1 2020 97 14623  2008 17 1689  1997 3 228  
2 2004 39 5238  2016 15 1437  1999 3 205  
3 2005 39 4394  2011 9 1330  2001 1 164  
4 2003 15 3296  2010 11 1158  2018 3 162  
5 2014 28 2809  2009 9 1045  1993 2 160  
6 2015 26 2637  2019 8 980  1995 1 153  
7 2007 15 2192  2012 10 858  1998 2 130  
8 2006 24 1983  2000 6 589  1994 1 66  
9 2013 14 1755  2002 5 534  1992 1 54  
10 2017 16 1699  1996 5 380     
Table 6: Average Citations per Year 
Year N MeanTCperArt MeanTCperYear CitableYears 
2020 97 150.7525773 
 
0 
2004 39 134.3076923 8.394230769 16 
2005 39 112.6666667 7.511111111 15 
2014 28 100.3214286 16.7202381 6 
2015 26 101.4230769 20.28461538 5 
2006 24 82.625 5.901785714 14 
2008 17 99.35294118 8.279411765 12 
2017 16 106.1875 35.39583333 3 
2003 15 219.7333333 12.9254902 17 
2007 15 146.1333333 11.24102564 13 
2016 15 95.8 23.95 4 
2013 14 125.3571429 17.90816327 7 
2010 11 105.2727273 10.52727273 10 
2012 10 85.8 10.725 8 
2009 9 116.1111111 10.55555556 11 
2011 9 147.7777778 16.41975309 9 
2019 8 122.5 122.5 1 
2000 6 98.16666667 4.908333333 20 
1996 5 76 3.166666667 24 
2002 5 106.8 5.933333333 18 
1997 3 76 3.304347826 23 
1999 3 68.33333333 3.253968254 21 
2018 3 54 27 2 
1993 2 80 2.962962963 27 
1998 2 65 2.954545455 22 
1992 1 54 1.928571429 28 
1994 1 66 2.538461538 26 
1995 1 153 6.12 25 
2001 1 164 8.631578947 19 
 
Journal wise distribution of Citations (159) 
The scientific literature on Covid-19 Vaccine is spread over 159 different source journals. 
Table 7 gives the leading journals each with number of publications and number of citations. The 
highly productive (Citations) journals are: JOURNAL OF VIROLOGY with 5724 Citations for 
53  Publications, SCIENCE with 4163 Citations for 13 publications, PROCEEDINGS OF THE 
NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA  with 
3113 Citations for 20 publications, NATURE with 2250 Citations for 13 publications, and 
LANCET with 1528 Citations for 8 publications. Table 8 shows Source impact of top 10 source 
title are listed in terms of cumulative number. The study found that most of the publications are 







Table 7: Most Cited Journals (159) 
Sl. 
No 
Journal (CiteSCore) Records  TLCS TGCS  
1 JOURNAL OF VIROLOGY – 7.9 53 483 5724  
2 SCIENCE 13 154 4163  
3 PROCEEDINGS OF THE NATIONAL ACADEMY OF 
SCIENCES OF THE UNITED STATES OF AMERICA- 
15.7 
20 299 3113  
4 NATURE 13 101 2250  
5 LANCET 8 97 1528  
6 VACCINE 18 134 1447  
7 CELL 2 19 1251  
8 AVIAN PATHOLOGY 9 49 1008  
9 VIROLOGY 12 98 981  
10 NATURE COMMUNICATIONS 6 0 974  
11 NATURE MEDICINE 4 50 875  
12 VIRUSES-BASEL 8 2 869  
13 PLOS PATHOGENS 6 0 824  
14 JOURNAL OF MEDICAL VIROLOGY 8 12 747  
15 CLINICAL MICROBIOLOGY REVIEWS 3 9 714  
16 BIOCHEMICAL AND BIOPHYSICAL RESEARCH 
COMMUNICATIONS 
5 87 682  
17 ARCHIVES OF VIROLOGY 8 14 674  
18 JOURNAL OF GENERAL VIROLOGY 7 40 650  
19 NATURE REVIEWS MICROBIOLOGY 2 61 624  
20 VIROLOGY JOURNAL 5 0 612  
21 JOURNAL OF INFECTIOUS DISEASES 7 22 574  
22 EMERGING INFECTIOUS DISEASES 5 26 568  
23 JOURNAL OF IMMUNOLOGY 6 68 556  
24 JOURNAL OF VIROLOGICAL METHODS 6 8 555  







Table 8: Source Dynamic 
Year SCIENCE JOURNAL 
OF 
VIROLOGY 
















1992 0 0 0 0 0 0 0 0 
1993 0 0 0 0 0 0 0 0 
1994 0 0 0 0 0 0 0 0 
1995 0 0 0 0 0 0 0 0 
1996 0 1 0 0 0 0 0 1 
1997 0 2 0 0 0 0 0 2 
1998 0 2 0 0 0 0 0 2 
1999 0 2 0 0 1 0 0 2 
2000 0 2 0 0 2 0 0 2 
2001 0 3 0 0 2 0 0 2 
2002 0 4 0 0 2 0 0 3 
2003 1 6 2 0 3 0 0 4 
2004 1 16 3 1 6 1 0 4 
2005 2 21 3 1 9 1 0 7 
2006 2 24 3 1 9 2 0 8 
2007 3 26 3 1 11 2 0 8 
2008 3 28 3 1 12 2 0 9 
2009 3 28 3 1 12 3 0 9 
2010 3 33 3 1 12 3 0 9 
2011 3 36 4 1 12 3 0 9 
2012 3 36 4 1 12 3 2 9 
2013 3 40 4 1 13 3 3 9 
2014 3 44 4 2 15 3 4 9 
2015 3 51 4 2 16 3 4 9 
2016 4 51 4 3 17 3 4 9 
2017 4 51 4 3 20 3 4 9 
2018 4 51 4 3 20 3 5 9 
2019 4 51 4 3 20 3 5 9 





Most Cited Authors (2924) 
Table 9 shows the ranking of authors / Citation received. In the rank list the contributors 
who have received more than 1500 Citations or more are taken into account to avoid a long list. 
Baric RS has contributed 24 articles (3232 Citations) and followed by Subbarao K contributed 20 
articles(3071 Citations), Jiang SB contributed 23 articles(2668 Citations). Others have recorded 
less than 1500 Citations during the period of study. In the analysis it has been observed that most 
of the ranked contributors are from USA and China. The study found that 94 authors received 
more than 1000 Citations and 189 authors received more than 500 Citations. Table 10 shows 
impact of authors in terms of H-Index, G-Index and M-Index values.  
 
 
Table 9: Most Cited Authors 
# Author Records  TGCS   Author Records TGCS  
1 Baric RS 24 3232   Perlman S 18 1759  
2 Subbarao K 20 3071   Corbett KS 4 1636  
3 Jiang SB 23 2668   Czub M 3 1628  
4 Zhou YS 17 2600   Feldmann H 3 1611  
5 Du LY 16 2396   Andonov A 3 1592  
6 Yuen KY 12 2181   Jones S 3 1592  
7 Roberts A 14 1980   Denison MR 10 1585  
8 Graham BS 7 1959   Graham RL 9 1577  
9 Li Y 7 1923   Farzan M 8 1572  
10 Wang NS 5 1859   Li F 5 1544  
11 Vogel L 13 1834   Grolla A 2 1533  
12 McLellan JS 6 1811   Roper RL 3 1514  
 
Table 10: Author Impact 
Author h_index g_index m_index TC NP PY_start 
BARIC RS 24 24 1.26 3232 24 2002 
JIANG SB 23 23 1.35 2668 23 2004 
SUBBARAO K 20 20 1.18 3071 20 2004 
PERLMAN S 18 18 1.38 1759 18 2008 
ZHOU YS 17 17 1.00 2600 17 2004 
DU LY 16 16 0.94 2396 16 2004 
ENJUANES L 14 14 0.56 1437 14 1996 
ROBERTS A 14 14 0.82 1980 14 2004 
VOGEL L 13 13 0.76 1834 13 2004 
SAIF LJ 12 12 0.43 931 12 1993 
YUEN KY 12 12 0.71 2181 12 2004 
ZHAO JC 12 12 1.09 1298 12 2010 
HE YX 11 11 0.65 1304 11 2004 
DENISON MR 10 10 0.56 1585 10 2003 
 
Figure: Three Field Plot (Authors, Institutions and Countries 
Highly Cited papers 
The highly cited 10 Covid-19 Vaccine publications during the period of study are listed 
in Table 11. The most frequently cited one was “Marra MA, Jones SJM, Astell CR, Holt RA, 
Brooks-Wilson A, et al., The genome sequence of the SARS-associated coronavirus, SCIENCE. 
2003 MAY 30; 300 (5624): 1399-1404” with 1374 citations followed by Wrapp D, Wang NS, 
Corbett KS, Goldsmith JA, Hsieh CL, et al., Cryo-EM structure of the 2019-nCoV spike in the 
prefusion conformation, SCIENCE. 2020 MAR 13; 367 (6483): 1260-+ with 1202 Citations. 
Table 11: Highly Cited Papers 





1 43 Marra MA, Jones SJM, Astell CR, Holt 
RA, Brooks-Wilson A, et al., The genome 
sequence of the SARS-associated 
coronavirus 
SCIENCE. 2003 MAY 30; 300 (5624): 
1399-1404  
1374 32  Canada 59 76.33 
2 354 Wrapp D, Wang NS, Corbett KS, 
Goldsmith JA, Hsieh CL, et al., Cryo-EM 
structure of the 2019-nCoV spike in the 
prefusion conformation, SCIENCE. 2020 
MAR 13; 367 (6483): 1260-+  
1202 45  USA 8 1202 
3 366 Walls AC, Park YJ, Tortorici MA, Wall 
A, McGuire AT, et al. 
Structure, Function, and Antigenicity of the 
985 99  USA,  
France 
6 985 
SARS-CoV-2 Spike Glycoprotein, CELL. 
2020 APR 16; 181 (2): 281-+  
4 349 Wan YS, Shang J, Sun SH, Tai WB, 
Chen J, et al. 
Molecular Mechanism for Antibody-
Dependent Enhancement of Coronavirus 
Entry, JOURNAL OF VIROLOGY. 2020 
MAR; 94 (5): Art. No. e02015-19  
705 64  USA,  
China 
13 705 
5 120 Li F, Li WH, Farzan M, Harrison SC., 
Structure of SARS coronavirus spike 
receptor-binding domain complexed with 
receptor, SCIENCE. 2005 SEP 16; 309 
(5742): 1864-1868  
606 33  USA 4 37.88 
6 211 Ruuskanen O, Lahti E, Jennings LC, 
Murdoch DR 
Viral pneumonia, LANCET. 2011 APR 9; 
377 (9773): 1264-1275  
520 152  Finland,  
New Zealand 
4 52 
7 89 Peiris JSM, Guan Y, Yuen KY., Severe 
acute respiratory syndrome, NATURE 
MEDICINE. 2004 DEC; 10 (12): S88-S97  
469 147  China 3 27.59 
8 162 Cavanagh D., Coronavirus avian 
infectious bronchitis virus 
VETERINARY RESEARCH. 2007 FEB-
MAR; 38 (2): 281-297  
444 103  England 1 31.71 
9 59 Yang ZY, Kong WP, Huang Y, Roberts 
A, Murphy BR, et al. 
A DNA vaccine induces SARS coronavirus 
neutralization and protective immunity in 
mice, NATURE. 2004 APR 1; 428 (6982): 
561-564  
393 23  USA 7 23.12 
10 190 Du LY, He YX, Zhou YS, Liu SW, 
Zheng BJ, et al. 
The spike protein of SARS-CoV - a target 
for vaccine and therapeutic development, 
NATURE REVIEWS MICROBIOLOGY. 
2009 MAR; 7 (3): 226-236  




Figure: Three Field Plot (Titles, authors and Countries) 
FINDINGS AND CONCLUSION 
As per the Web of Science database, a total of 433 publications were published on Covid-
19, which received 52567 citations during 1989-2020. The average number of citations per 
publication was 121.4. The research was peaked in 2020 with 97(Which received minimum 500 
Citations) Publications, and the highest number of citations (14623) were received in 2020. The 
exponential growth of publications was observed. This may be attributed to a new field for 
research to demystify the phenomena of Covid-19 Vaccine. There were 18 single Author 
publications by the scientists and 2906 multi-Author collaborative publications. The 
Collaboration Index is 7.05 and Citing Articles (References) 15055.  
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